Amanda J. Pierz, MSc (she/her)

López-Castro T, Jakubowski A, Masyukova M, Peterson M, Pierz A, Kodali S, Julia H. Arnsten JH, Starrels JL, Nahvi S. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic. JSAT 2023:151. doi: 10.1016/j.josat.2023.209235
 

Masoud D, Pierz A, Rauh L, et al. Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust. Vaccine. doi: 10.1016/j.vaccine.2023.06.025
 

Pierz AJ, Rauh L, Masoud D, Cruz AK, Palmedo C, Ratzan SC, Parker R. Supporting US Healthcare Providers for Successful Vaccine Communication. BMC Health Services Research 2023:23(4). doi: 10.21203/rs.3.rs-2440427/v1
 

Murenzi G, Shumbusho F, Hansen N, Munyaneza A, Gage JC, Muhoza B, Kanyabwisha F, Pierz A, Tuyisenge P, Anastos K, Castle PE. Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol. BMJ 2022;12,(8). doi: 10.1136/bmjopen-2022-061650.
 

Pierz AJ & Dapi LN. Traditional and colonial governance practices and their impact on women’s identities and experiences in French Cameroon: a retrospective study. Social Identities 2021. doi: 10.1080/13504630.2021.1997734.
 

Adedimeji AA, Ajeh R, Pierz A, Nkeng R, Ndenkeh J, Fuhngwa N, Nsame D, Nji M, Dzudie A, Anastos KM, Castle PE. Challenges and opportunities to reduce the burden of cervical cancer in a low income, high HIV prevalence context. BMC Women’s Health 2021. doi: 10.21203/rs.2.20620/v2. 
 

Marcus JZ, Adedin Y, Pierz AJ, Taveras Y, Sollecito CC, Parmar H, Burk RD, Castle PE. A pilot study of human papillomavirus detection in urine using a novel nucleic acid amplification test. J Clin Microbio 2021;1-6. doi: 0.1093/jalm/jfaa238. 
 

Pierz AJ, Ajeh R, Fuhngwa N, Nasah J, Dzudie A, Nkeng R, Anastos KM, Castle PE, Adedimeji A. Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in Limbé, Cameroon. Front Repro Health 2021;2. doi: 10.3389/frph.2020.561202. 
 

Castle P, Pierz A, Adcock R, Aslam S, Basu P, Belinson J, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco  E, Gravitt P, Isidean S, Li J, Mahmud S, Monsonego J, Muwonge R, Ratnam S, Safaeian M, Xi, L. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prevention Research 2020;0182.2020. doi: 10.1158/1940-6207.CAPR-20-0182. 
 

Castle P, Ajeh R, Dzudie A, Kendowo E, Fuhngwa N, Simo W, Andre G, Nsame D, Orock E, Hébert T, Pierz A, Murokora D, Anastos K, Adedimeji A. A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon. Infectious Agents and Cancer 2020;15. doi: 10.1186/s13027-020-00311-w. 
 

Pierz AJ, Randall TC, Castle PE, Adedimeji A, Ingabire C, Kubwimana G, Uwinkindi F, Hagenimana M, Businge L, Musabyimana F, Munyaneza A, Murenzi G. A scoping review: Facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer in Sub-Saharan African health settings. Gyn Onc Reports 2020;33:100605. doi: 10.1016/j.gore.2020.100605. 
 

Adedimeji A, Ajeh R, Dzudie A, Kendowo E, Fuhngwa N, Nsame D, Simo-Wambo AG, Orock E, Hebert TM, Pierz AJ, Murokora D, Anastos K, Castle PE. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon, J Clin Virol 2020;128(104445). doi: 10.1016/j.jcv.2020.104445. 
 

Castle P, Silva V, Consolaro M, Kienen N, Bittencourt L, Pelloso S, Partridge E, Pierz A, Dartibale C, Uchimura N, and Scarinci I. Participation in cervical screening by self-collection, Pap, or a choice of either in Brazil. Cancer Prevention Research 2019;12(3):159-169. doi: 10.1158/1940-6207.capr-18-0419.
 

Castle P & Pierz A. (At Least) Once in a Lifetime: Global Cervical Cancer Prevention. Obstetrics and Gynecology Clinics of North America 2019;46(1):107-123. doi: 10.1016/j.ogc.2018.09.007. 
 

Castle PE, Pierz AJ, Stoler MH. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecological Oncology 2018;148(2):422-429. doi: 10.1016/j.ygyno.2017.12.001.